CDC Warns of Surge in Bacterial Illness Leading to Meningitis

Introduction

The Centers for Disease Control and Prevention (CDC) has issued a critical alert regarding a concerning surge in a rare bacterial illness that can lead to meningitis, a serious condition affecting the brain and spinal cord. 

This alert, directed at healthcare professionals, highlights a significant increase in cases of invasive meningococcal disease, particularly caused by a specific strain of bacteria. In 2023, the U.S. witnessed 422 reported cases of this bacterial infection, marking the highest number since 2014. 

Already this year, 143 cases have been reported, indicating a worrying trend towards surpassing the previous year's figures. The CDC emphasizes that most cases last year did not involve meningitis, but the severity of the illness is underscored by at least 17 reported deaths. Notably, these cases disproportionately affected adults aged 30 to 60, Black individuals, and those with HIV. 

The bacterial infection can manifest as meningitis, characterized by symptoms like fever, headache, stiff neck, nausea, and vomiting, or as a bloodstream infection with distinct signs such as chills, fatigue, and a dark purple rash in later stages. 

Treatment with antibiotics is crucial, as the infection can lead to severe complications, with a mortality rate of 10% to 15% and potential long-term consequences for survivors. 

Vaccination against meningococcal disease is recommended, especially for children entering middle school and individuals at higher risk due to specific health conditions or outbreak situations.

Sign and Symptoms 

The symptoms of meningococcal disease, caused by the bacteria Neisseria meningitidis, can vary but commonly include:

• General poor feeling
• Sudden high fever
• Severe, persistent headache
• Neck stiffness
• Nausea or vomiting
• Discomfort in bright lights
• Drowsiness or difficulty awakening
• Joint pain
• Confusion or other mental changes
• A reddish or purple skin rash (petechiae) that does not turn white when pressed, indicating a medical emergency.

current vaccination rate

The current vaccination rates for meningococcal disease in the United States are concerning, with low percentages of individuals receiving the recommended vaccines. A nationwide retrospective database study revealed that only 4.6% and 2.2% of patients were estimated to have received MenACWY and MenB vaccinations, respectively. 

Specifically, MenACWY vaccination rates were low among those aged 11–18 years, with only 13.0% receiving MenB vaccinations among those aged 10–18 years. 

These low vaccination rates are alarming, especially among adults with newly diagnosed chronic diseases, where meningococcal vaccination rates were extremely low despite recommendations to vaccinate this at-risk population. The study highlighted a critical need to increase the coverage of meningococcal vaccinations among patients with chronic diseases.Additionally, the CDC has issued alerts regarding meningococcal disease, emphasizing the importance of staying up to date with recommended vaccines to protect against this severe bacterial illness. 

The CDC's Health Alert Network reported a surge in invasive serogroup Y meningococcal disease in the U.S., underlining the severity and potential risks associated with this disease. It's crucial to be aware that even individuals who have received meningococcal vaccines could still be at risk of contracting meningococcal disease, especially if they have certain risk factors like receiving complement inhibitors.

cost of meningococcal vaccination

The cost of meningococcal vaccination in the United States can vary depending on the specific type of vaccine and where it is administered. For instance, the Meningococcal MCV4 vaccine is priced at $180 per dose, while the Meningococcal B vaccine costs $215 per dose. 

It's important to note that the Meningococcal B vaccine is offered in two doses specifically for individuals aged 18-22 years. Additionally, there may be administration fees associated with these vaccinations, with some sources mentioning an administration fee of up to $21.22 per shot for the meningococcal vaccine.

Side effects

The MenACWY vaccine is recommended for teenagers and young adults to protect against meningitis, sepsis, and septicaemia caused by specific bacteria. It is usually given at ages 13-14, with the option to receive it until age 25. 

The vaccine is administered as an injection in the upper arm, with most individuals needing only one dose. Common side effects include pain, swelling, headache, nausea, rash, irritability, drowsiness, and loss of appetite, with severe allergic reactions being very rare.The MenACWY vaccine is crucial for students, especially those starting college or university, as meningitis can spread rapidly in such environments. It is also recommended for individuals at increased risk due to medical conditions, work, travel, or close contact with infected individuals. 

The vaccine does not contain live bacteria, eliminating the risk of infection from the vaccine itself. It is essential to be aware of meningitis symptoms even after vaccination, as the vaccine does not protect against all types of meningitis.

Long term effects

The meningococcal vaccine is crucial for protecting against meningococcal disease, which can lead to severe health issues like meningitis, blood infections, and even death. 

The vaccine is recommended for adolescents and adults at risk, including those living in dorms, working with meningococcal bacteria, or traveling to high-risk areas. Common side effects of the vaccine include mild pain, redness at the injection site, and slight fever.While the vaccine is generally safe, some sources raise concerns about serious side effects like neurological disorders and death, especially when given alongside other vaccinations. 

Studies have linked the meningococcal vaccine to an increased risk of neurological issues, and there have been reports of adverse events following vaccination, including deaths. The vaccine's effectiveness against certain bacterial strains is also questioned, with limited protection against the most common strain responsible for infections.

The Bottom Line

Understanding the risks, symptoms, and preventive measures related to meningococcal disease is crucial for maintaining public health and individual well-being. Vaccination remains a key strategy in preventing this potentially life-threatening bacterial infection, especially for at-risk populations such as adolescents, young adults, and individuals with specific medical conditions. 

While the meningococcal vaccine can have side effects, the benefits of protection against meningitis, sepsis, and other serious complications far outweigh the risks associated with the vaccine. 

Healthcare providers need to educate patients about the importance of vaccination, recognize the symptoms of meningococcal disease, and promptly seek medical attention if any concerning signs appear. By staying informed, promoting vaccination, and being vigilant about symptoms, we can work towards reducing the incidence of meningococcal disease and safeguarding public health.